I was just thinking about progress to date and it occured to me things could be better than i thought. Not only have we developed a technology that can scan cells and find suitable fpp's the thing that dawned on me is we currently have a number of fpp's that are shown to be better by huge margin than the current gold standard tat. That is not the big news but the thing is the fpp is from our library and owned by us, so once it is validated anyone who wants to use it would have to come to us. Maybe this is why the excitement started building when genentech extended. As has been discussed it seems not much has actually been done with tat in a commercial sense. Maybe this is partly because of its effectiveness. If genentech are first cab and even hint that maybe this is something they can use rather than just taking a look or kicking tyres then it could explode. 2 million milestone hints in that direction. Hard to believe anyone else can do better. Maybe im just excited cos Richmond won but for some reason it just seemed to sink in that this could revolutionise medicine and drugging the undruggable maybe with a range of ip protected fpp's. Happy days ahead hopefully.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)